Sanifit therapeutics
Webb22 nov. 2024 · Le laboratoire saint-gallois Vifor annonce lundi l'acquisition de deux concurrents: l'espagnol Sanifit Therapeutics et le zurichois Inositec. Tous deux développent des traitements contre la ... Webb18 juni 2024 · J.P. and B.I. are founders, employees and stockholders of Sanifit Therapeutics and co-inventors of patents owned or controlled by Sanifit Therapeutics. M.D.F. has received research grants and travel support from Sanifit Therapeutics, is a stockholder of Sanifit Therapeutics and is a co-inventor of a patent owned or controlled …
Sanifit therapeutics
Did you know?
Webb1 dec. 2024 · CSL Vifor, a world leading Nephrology, Iron Deficiency and Cardio-Renal pharmaceutical company, is experiencing rapid growth due to the realization, continued expansion, and optimization of its pipeline and portfolio strategy.We are currently looking for a Medical Affairs Officer (Quality Assurance, Regulatory Affairs, Pharmacovigilance) … Webb22 nov. 2024 · Sanifit’s SNF472 is a novel, first-in-class inhibitor of vascular calcification in phase-III, developed for the treatment of calcific uremic arteriolopathy (CUA) and …
WebbFounders Joan Perelló. Operating Status Active. Last Funding Type Series D. Legal Name SANIFIT THERAPEUTICS, S.A. Company Type For Profit. Contact Email … Webb3 juni 2016 · Sanifit Therapeutics S. A. ClinicalTrials.gov Identifier: NCT02790073 Other Study ID Numbers: SNFCT2015_04 : First Posted: June 3, 2016 Key Record Dates: Results First Posted: August 28, 2024: Last Update Posted: August 28, 2024 Last Verified: August 2024 Keywords ...
Webb28 apr. 2024 · About Cara Therapeutics Cara Therapeutics is an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company’s novel KORSUVA ™ (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated … Webb9 apr. 2024 · Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas. PARIS …
Webb12 apr. 2024 · Los dos primeros fondos lanzados por Columbus en 2016 de €41 millones y en 2024 de €74 millones están en fase muy avanzada de desinversión tras un impresionante historial de rendimiento con 9 desinversiones exitosas como Viralgen Vector Core, Viralgen Comercial, y Askbio (adquiridas por Bayer), Curapath (adquirida …
WebbVIFOR PHARMA : Noticias, novedades e información acción VIFOR PHARMA VIFN CH0364749348 Swiss Exchange eventi windows 10WebbSalcedo, Carolina, Sanifit Therapeutics, Palma, Balearic Islands, Spain; Background. Micro-computed tomography (micro-CT) scanning could be an alternative technique of both visualization and quantification of calcium content in vessels. Our aim was to ... eventix btwWebb22 nov. 2024 · Sanifit Therapeutics and Inositec AG, both clinical stage biopharmaceutical companies, are developing first-in-class treatments for progressive vascular calcification and soft tissue disorders. Sanifit’s SNF472 is a novel, first-in-class inhibitor of vascular calcification in phase-III, developed for the treatment of calcific uremic ... eventix incWebb22 nov. 2024 · Vifor Pharma has announced the acquisition of Sanifit Therapeutics, a Spanish clinical-stage cardio-renal biopharmaceutical company focused on treatments for end-stage kidney disease patients with progressive vascular calcification disorders, and Inositec AG, a Swiss company, developing first-in-class non-dialysis treatments for soft … eventix inlogfirst hyperionWebbVifor Pharma to spearhead development of vascular calcification field, through acquisition of Sanifit Therapeutics and Inositec AG. ... • Sanifit purchase price includes an upfront payment of EUR 205 million, precommercial milestones for up to EUR 170 million and progressive commercial milestones. first hyperion texasWebb22 nov. 2024 · Sanifit Therapeutics and Inositec AG, both clinical stage biopharmaceutical companies, are developing first-in-class treatments for progressive vascular calcification … eventix refund